NCT03439410

Brief Summary

The progressive rising of multimorbidity, which has been always considered the hallmark of clinical complexity (CC), has made management of the "complex" patient one of the most topical and challenging issues in medicine. However, patient-related factors (multimorbidity, age, frailty, disease severity) pertain only to the biological complexity, while CC is the result of the dynamic interaction between biological complexity and a number of other coexisting factors (socio-economic, cultural, behavioural, environmental). Starting from these premises, the investigators designed a five-year observational prospective longitudinal study that aims to validate and compare a CC score system on a large cohort of patients (n=1000) admitted in internal medicine wards. Clinicians, biostatisticians and epidemiologists will cooperate into the project. A questionnaire that encompasses the main biological and extra-biological factors was designed (Clinical Complexity Index, CCI) by a multiprofessional consensus. This questionnaire will be administered by the investigators to the patients and validated. Consecutive patients will be enrolled every other week for two years and followed-up for 5 years. The primary endpoint will be the validation of the CCI. Thereafter, the investigators will evaluate the correlation between the CCI and the length of stay of the index hospitalization, assuming that a higher CCI score is associated with longer length of stay. The secondary endpoints will be the demonstration of the association between higher CCI score and more health resources utilization (i.e., evaluating occurrence of hospital readmissions, number of accesses to the emergency room, visits at the outpatient clinic, different drugs prescribed and hospital reimbursement according to the local diagnosis-related group \[DRG\] system) along with worse prognosis (mortality at 1 and 5 years).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 6, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 20, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2019

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2022

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

2 years

First QC Date

February 6, 2018

Last Update Submit

February 25, 2019

Conditions

Keywords

Internal medicineChronic diseaseHealthcare expenditure

Outcome Measures

Primary Outcomes (1)

  • Validation of the Clinical Complexity Index (CCI)

    Validation of the Clinical Complexity Index (CCI) proposed in the project (see first Citation and Study Description for further details). This index should measure patients' clinical complexity, including biological, socioeconomic, cultural, behavioral, and envirnomental domains. The total score range is -25 to +25 (-5 to +5 per each domain). The investigators expect that a higher value is associated with a worse outcome (higher clinical complexity).

    2 years

Secondary Outcomes (3)

  • Length of stay

    2 years

  • Healthcare expenditure and utilization

    1 year

  • Mortality

    5 years

Study Arms (2)

Internal Medicine ward

The Clinical Complexity Index (CCI) will be administered to all patients admitted to the ward.

Other: Clinical Complexity Index

Subacute ward

The Clinical Complexity Index (CCI) will be administered to all patients admitted to the ward.

Other: Clinical Complexity Index

Interventions

Clinical Complexity Index (CCI) will be administered at the time of admission to the ward.

Internal Medicine wardSubacute ward

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients admitted in the aforementioned wards will be enrolled in the study during the time of the study

You may qualify if:

  • Age ≥ 18
  • Hospitalized in one of the participating Units (Internal Medicine wards or Subacute ward)

You may not qualify if:

  • Already enrolled in the study during a previous hospitalization
  • Denied informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo

Pavia, Lombardy, 27100, Italy

RECRUITING

Related Publications (3)

  • Palese A, Brusaferro S. A multidimensional vector model measuring clinical complexity may increase effectiveness in patient assessment. Intern Emerg Med. 2017 Dec;12(8):1287-1289. doi: 10.1007/s11739-017-1722-9. Epub 2017 Aug 4. No abstract available.

    PMID: 28779449BACKGROUND
  • Corazza GR, Klersy C, Formagnana P, Lenti MV, Padula D; Consensus Panel. A consensus for the development of a vector model to assess clinical complexity. Intern Emerg Med. 2017 Dec;12(8):1313-1318. doi: 10.1007/s11739-017-1709-6. Epub 2017 Jul 14.

  • Lenti MV, Brera AS, Ballesio A, Croce G, Padovini L, Bertolino G, Di Sabatino A, Klersy C, Corazza GR. Resilience is associated with frailty and older age in hospitalised patients. BMC Geriatr. 2022 Jul 10;22(1):569. doi: 10.1186/s12877-022-03251-9.

MeSH Terms

Conditions

BehaviorChronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gino R Corazza, MD

    Fondazione IRCCS Policlinico San Matteo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Internal Medicine

Study Record Dates

First Submitted

February 6, 2018

First Posted

February 20, 2018

Study Start

November 6, 2017

Primary Completion

November 6, 2019

Study Completion

November 6, 2022

Last Updated

February 26, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will share

All individual participant data (IPD), anonymized and aggregated, that underlie results in a publication.

Shared Documents
SAP, CSR
Time Frame
Only on future articles that will be published.

Locations